Smoking is widely recognised as a major cause of serious illnesses and premature deaths, but researchers have identified an unexpected association between tobacco use and a lower risk of developing Parkinson’s disease.

Several scientific studies have examined this connection, with findings suggesting that smokers may have a lower likelihood of developing the progressive neurological disorder compared with non-smokers. However, researchers stress that these findings do not mean smoking is beneficial or safe.

A 2020 study published in the journal Neurology followed approximately 30,000 male British doctors over 65 years.

Researchers found that doctors who continued smoking had a 40 per cent lower risk of Parkinson’s disease compared with those who had never smoked.

A more recent study, published in JAMA Neurology on September 8, 2026, examined data from more than 512,000 adults in China.

The researchers, including scientists from the University of Oxford and China, found that regular smokers had approximately 30 per cent lower risk of developing Parkinson’s disease.

Interestingly, the study also found that non-smokers with higher levels of carbon monoxide in their exhaled breath had a lower risk of the disease.

This finding has raised new questions about the possible role of carbon monoxide in Parkinson’s disease.

Parkinson’s disease is a progressive neurological disorder that affects movement and the nervous system. Common symptoms include involuntary shaking, slowed movement, muscle stiffness and difficulties with balance.

The condition is associated with the gradual loss of dopamine-producing nerve cells in the brain. As the disease progresses, patients may experience increasing difficulties with everyday activities and require assistance from others.

Scientists are investigating several possible explanations for the association between smoking and Parkinson’s disease.

One possible factor is carbon monoxide, a toxic gas produced during tobacco combustion. Researchers found that higher levels of exhaled carbon monoxide were associated with a lower risk of Parkinson’s disease, even among people who had never smoked.

In small amounts, carbon monoxide is also naturally produced by the human body and may influence biological processes, including inflammation. Scientists are investigating whether these mechanisms could help explain the observed association.

Nicotine is another substance being studied because of its interaction with dopamine-related pathways in the brain.

Researchers have also examined the possible role of other chemicals in tobacco, including their effects on enzymes involved in dopamine breakdown.

However, these explanations remain areas of scientific investigation and do not establish that smoking prevents Parkinson’s disease.

Despite these findings, smoking remains a major health hazard associated with cancer, heart disease, stroke and several other serious conditions.

Researchers have not recommended smoking as a way to prevent Parkinson’s disease. Further studies are needed to understand the biological mechanisms behind the observed relationship and determine whether any individual compounds could have potential medical applications.

READ ALSO: Smoking may speed up mental decline, research finds

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts